Telix Pharmaceuticals (TLX) Accumulated Depreciation & Amortization (2023 - 2024)
Telix Pharmaceuticals has reported Accumulated Depreciation & Amortization over the past 2 years, most recently at $2.0 million for Q4 2024.
- Quarterly Accumulated Depreciation & Amortization rose 58.15% to $2.0 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $2.0 million through Dec 2024, up 58.15% year-over-year, with the annual reading at $2.0 million for FY2024, 58.15% up from the prior year.
- Accumulated Depreciation & Amortization was $2.0 million for Q4 2024 at Telix Pharmaceuticals, up from $1.3 million in the prior quarter.
- Over five years, Accumulated Depreciation & Amortization peaked at $2.0 million in Q4 2024 and troughed at $1.3 million in Q4 2023.